MiRNA expression deregulation correlates with the Oncotype DX(®) DCIS score

BACKGROUND: Current clinical criteria do not discriminate well between women who will or those who will not develop ipsilateral invasive breast cancer (IBC), or a DCIS recurrence after a ductal carcinoma in situ (DCIS) diagnosis. The 12-gene Oncotype DX® DCIS assay (RT qPCR gene-based scoring system...

Descripción completa

Detalles Bibliográficos
Autores principales: Loudig, Olivier, Mitchell, Megan I., Ben-Dov, Iddo Z., Liu, Christina, Fineberg, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469592/
https://www.ncbi.nlm.nih.gov/pubmed/36096802
http://dx.doi.org/10.1186/s13058-022-01558-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469592/
https://www.ncbi.nlm.nih.gov/pubmed/36096802
http://dx.doi.org/10.1186/s13058-022-01558-4

Ejemplares similares